Literature DB >> 28544727

Ultraviolet radiation accelerates NRas-mutant melanomagenesis: A cooperative effect blocked by sunscreen.

Rebecca C Hennessey1, Andrea M Holderbaum1,2, Anamaria Bonilla1,2, Conor Delaney1, James E Gillahan1, Kathleen L Tober3, Tatiana M Oberyszyn3, Jonathan H Zippin4, Christin E Burd1,2.   

Abstract

To mitigate melanoma risk, sunscreen use is widely advocated; yet, the ability of sunscreens to prevent melanoma remains controversial. Here, we test the tenet that sunscreens limit melanoma risk by blocking ultraviolet radiation (UV)-induced DNA damage using murine models that recapitulate the genetics and spontaneous evolution of human melanoma. We find that a single, non-erythematous dose of UV dramatically accelerates melanoma onset and increases tumor multiplicity in mice carrying an endogenous, melanocyte-specific NRas61R allele. By contrast, transient UV exposure does not alter tumor onset in mice lacking p16INK4a or harboring an NRas12D allele. To block the rapid onset of melanoma cooperatively caused by UV and NRas61R , we employed a variety of aerosol sunscreens. While all sunscreens delayed melanoma formation and blocked UV-induced DNA damage, differences in aerosol output (i.e., amount applied/cm2 ) caused variability in the cancer preventative efficacy of products with identical sunburn protection factor (SPF) ratings.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NRAS; melanoma; mouse model; sunscreen; ultraviolet

Mesh:

Substances:

Year:  2017        PMID: 28544727     DOI: 10.1111/pcmr.12601

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  12 in total

Review 1.  Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Authors:  Joanne M Jeter; Tawnya L Bowles; Clara Curiel-Lewandrowski; Susan M Swetter; Fabian V Filipp; Zalfa A Abdel-Malek; Larisa J Geskin; Jerry D Brewer; Jack L Arbiser; Jeffrey E Gershenwald; Emily Y Chu; John M Kirkwood; Neil F Box; Pauline Funchain; David E Fisher; Kari L Kendra; Ashfaq A Marghoob; Suephy C Chen; Michael E Ming; Mark R Albertini; John T Vetto; Kim A Margolin; Sherry L Pagoto; Jennifer L Hay; Douglas Grossman; Darrel L Ellis; Mohammed Kashani-Sabet; Aaron R Mangold; Svetomir N Markovic; Frank L Meyskens; Kelly C Nelson; Jennifer G Powers; June K Robinson; Debjani Sahni; Aleksandar Sekulic; Vernon K Sondak; Maria L Wei; Jonathan S Zager; Robert P Dellavalle; John A Thompson; Martin A Weinstock; Sancy A Leachman; Pamela B Cassidy
Journal:  Cancer       Date:  2018-10-03       Impact factor: 6.860

Review 2.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

3.  Novel insights into the pathogenesis and treatment of NRAS mutant melanoma.

Authors:  Jeffrey Zhao; Carlos Galvez; Kathryn Eby Beckermann; Douglas B Johnson; Jeffrey A Sosman
Journal:  Expert Rev Precis Med Drug Dev       Date:  2021-08-11

4.  Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation.

Authors:  Brandon M Murphy; Elizabeth M Terrell; Venkat R Chirasani; Tirzah J Weiss; Rachel E Lew; Andrea M Holderbaum; Aastha Dhakal; Valentina Posada; Marie Fort; Michael S Bodnar; Leiah M Carey; Min Chen; Craig J Burd; Vincenzo Coppola; Deborah K Morrison; Sharon L Campbell; Christin E Burd
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

Review 5.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

6.  Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity.

Authors:  Manali S Phadke; Zhihua Chen; Jiannong Li; Eslam Mohamed; Michael A Davies; Inna Smalley; Derek R Duckett; Vinayak Palve; Brian J Czerniecki; Peter A Forsyth; David Noyes; Dennis O Adeegbe; Zeynep Eroglu; Kimberly T Nguyen; Kenneth Y Tsai; Uwe Rix; Christin E Burd; Yian A Chen; Paulo C Rodriguez; Keiran S M Smalley
Journal:  Cancer Immunol Res       Date:  2021-03-02       Impact factor: 12.020

7.  Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice.

Authors:  Zhi Wen; Adhithi Rajagopalan; Evan D Flietner; Grant Yun; Marta Chesi; Quinlan Furumo; Robert T Burns; Athanasios Papadas; Erik A Ranheim; Adam C Pagenkopf; Zachary T Morrow; Remington Finn; Yun Zhou; Shuyi Li; Xiaona You; Jeffrey Jensen; Mei Yu; Alexander Cicala; James Menting; Constantine S Mitsiades; Natalie S Callander; P Leif Bergsagel; Demin Wang; Fotis Asimakopoulos; Jing Zhang
Journal:  Blood       Date:  2021-01-07       Impact factor: 25.476

Review 8.  Melanoma Risk and Melanocyte Biology.

Authors:  Julie U Bertrand; Eirikur Steingrimsson; Fanélie Jouenne; Brigitte Bressac-de Paillerets; Lionel Larue
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

9.  Melanoma-associated mutants within the serine-rich domain of PAK5 direct kinase activity to mitogenic pathways.

Authors:  Kyle M LaPak; Dennis C Vroom; Ayush A Garg; Xiangnan Guan; John L Hays; Jonathan W Song; Christin E Burd
Journal:  Oncotarget       Date:  2018-05-22

10.  Are FDA-Approved Sunscreen Components Effective in Preventing Solar UV-Induced Skin Cancer?

Authors:  Ann M Bode; Eunmiri Roh
Journal:  Cells       Date:  2020-07-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.